Stocks · Health care · Pharmaceutical Preparations

BridgeBio Pharma, Inc.

BBIO Clue Score39

United States Fiscal year ends December CIK 0001743881 Results filed 29 Oct 2026

Add to watchlist

What the insiders did Scheduled selling only

By person

19 insiders · 1 transaction

Insider

Role

Bought

Sold

Net

Holding

Of company

Worth

Change

Maricel Apuli

Chief Accounting Officer

—

$145.70K (1) scheduled

−$145.70K

120,687

0.0617%

$8.79M

−3.8%

Viking Global Investors LP entity

10% owner

—

—

—

18,555,375

9.49%

$1.35B

−26.1%

KKR Genetic Disorder L.P.

10% owner

—

—

—

13,260,971

6.78%

$966.06M

−47.5%

Neil Kumar

Chief Executive Officer

—

—

—

5,563,146

2.85%

$405.28M

−24.9%

Charles J Homcy

Director

—

—

—

919,876

0.4706%

$67.01M

−25.2%

Frank McCormick

Director

—

—

—

690,558

0.3532%

$50.31M

−32.5%

Thomas Trimarchi

President and CFO

—

—

—

336,529

0.1721%

$24.52M

−15.0%

Ali J. Satvat

Director

—

—

—

169,983

0.0870%

$12.38M

—

Brian C Stephenson

CFO and Treasurer

—

—

—

102,464

0.0524%

$7.46M

+20.1%

Andrew Lo

Director

—

—

—

68,662

0.0351%

$5.00M

−72.9%

Fred Hassan

Director

—

—

—

29,879

0.0153%

$2.18M

+54.8%

Andrea Ellis

Director

—

—

—

22,579

0.0116%

$1.64M

+88.2%

Ronald J Daniels

Director

—

—

—

20,981

0.0107%

$1.53M

+101.7%

James C Momtazee

Director

—

—

—

19,070

0.0098%

$1.39M

+124.6%

Randal W. Scott

Director

—

—

—

11,589

0.0059%

$844.26K

+131.8%

Douglas A. Dachille

Director

—

—

—

10,579

0.0054%

$770.68K

—

Eric Aguiar

Director

—

—

—

10,579

0.0054%

$770.68K

—

Hannah Valantine

Director

—

—

—

9,657

0.0049%

$703.51K

+61.5%

Jennifer E. Cook

Director

—

—

—

8,383

0.0043%

$610.70K

+17.2%